Published in Clin Med on January 19, 2005
An 8-year longitudinal analysis of UK ophthalmic publication rates. Eye (Lond) (2016) 0.80
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med (2003) 7.30
Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis (2010) 2.21
Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol (2004) 1.99
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis (2011) 1.88
Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis (2010) 1.81
Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol (2003) 1.61
The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl) (2008) 1.58
Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int (2013) 1.24
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids. Nephrol Dial Transplant (2009) 1.19
Is there a future for academic medicine in the UK? Hosp Med (2005) 1.10
Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr (2004) 0.93
Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. Circ Res (2013) 0.85
Monitoring dialysis outcomes across the world--the MONDO Global Database Consortium. Blood Purif (2013) 0.85
Confusing genes: a patient with MEN2A and Cushing's disease. Clin Endocrinol (Oxf) (2013) 0.80
Infliximab therapy for aggressive mooren ulceration. Arch Ophthalmol (2008) 0.80
CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology (Oxford) (2009) 0.79
Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. BMJ (2006) 0.78
Vasculitis syndromes: RAVE about rituximab in ANCA vasculitis? Nat Rev Nephrol (2013) 0.77
Bilateral subconjunctival masses as a rare presentation of Churg-Strauss syndrome. Ocul Immunol Inflamm (2013) 0.75
Cox-2 promotes chromogranin A expression and bioactivity: evidence for a prostaglandin E2-dependent mechanism and the involvement of a proximal cyclic adenosine 5'-monophosphate-responsive element. Endocrinology (2007) 0.75